If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||
  Journal of General Internal MedicineVolume 19 Issue 7, Pages 791 - 804 Published Online: 16 Jun 2004 © 2006 by the Society of General Internal Medicine. All rights reserved
Abstract | References | Full Text: HTML, PDF (Size: 293K) | Related Articles | Citation Tracking  Mortality Associated with Hormone Replacement Therapy in Younger and Older Women A Meta-analysis Received from the Department of Medicine, Santa Clara Valley Medical Center (SRS, EG, TMO), San Jose, Calif; Department of Medicine, Stanford University School of Medicine (SRS), Department of Medicine, Stanford, Calif; Department of Medicine (JMEW), University of California, San Francisco, Calif; and Center for Radiophysics and Space Research (EES), Cornell University, Ithaca, NY. Copyright © 2004 by the Society of General Internal Medicine KEYWORDS hormone replacement therapy • postmenopause • mortality • age factors • meta-analysis J GEN INTERN MED 2004;19:791–804. ABSTRACTOBJECTIVE: To assess mortality associated with hormone replacement in younger and older postmenopausal women. DESIGN: A comprehensive search of medline, cinahl, and embase databases was performed to identify randomized controlled trials of hormone replacement therapy from 1966 to September 2002. The search was augmented by scanning selected journals through April 2003 and references of identified articles. Randomized trials of greater than 6 months' duration were included if they compared hormone replacement with placebo or no treatment, and reported at least 1 death. MEASUREMENTS: Outcomes measured were total deaths and deaths due to cardiovascular disease, cancer, or other causes. Odds ratios (OR) for total and cause-specific mortality were reported separately for trials with mean age of participants less than and greater than 60 years at baseline. MAIN RESULTS: Pooled data from 30 trials with 26,708 participants showed that the OR for total mortality associated with hormone replacement was 0.98 (95% confidence interval [CI], 0.87 to 1.12). Hormone replacement reduced mortality in the younger age group (OR, 0.61; CI, 0.39 to 0.95), but not in the older age group (OR, 1.03; CI, 0.90 to 1.18). For all ages combined, treatment did not significantly affect the risk for cardiovascular or cancer mortality, but reduced mortality from other causes (OR, 0.67; CI, 0.51 to 0.88). CONCLUSIONS: Hormone replacement therapy reduced total mortality in trials with mean age of participants under 60 years. No change in mortality was seen in trials with mean age over 60 years. |  |
